{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981470040899072.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.coviro.2021.04.006"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1879625721000407?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1879625721000407?httpAccept=text/plain"}}],"dc:title":[{"@value":"Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381981470040898945","@type":"Researcher","foaf:name":[{"@value":"Koen Vandyck"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981470040898944","@type":"Researcher","foaf:name":[{"@value":"Jerome Deval"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"18796257"}],"prism:publicationName":[{"@value":"Current Opinion in Virology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2021-08","prism:volume":"49","prism:startingPage":"36","prism:endingPage":"40"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","https://doi.org/10.15223/policy-017","https://doi.org/10.15223/policy-037","https://doi.org/10.15223/policy-012","https://doi.org/10.15223/policy-029","https://doi.org/10.15223/policy-004"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1879625721000407?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1879625721000407?httpAccept=text/plain"}],"createdAt":"2021-04-27","modifiedAt":"2025-10-30","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360580230600916736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Binding and Unbinding Pathways of Peptide Substrates on the SARS-CoV-2 3CL Protease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588381045639424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593661640576","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Virtual Alanine Scan of the Main Protease Active Site in Severe Acute Respiratory Syndrome Coronavirus 2"}]},{"@id":"https://cir.nii.ac.jp/crid/1390016880929245056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"<i>In Silico</i> Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390852724622506112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Current status of structure-based drug repurposing against COVID-19 by targeting SARS-CoV-2 proteins"}]},{"@id":"https://cir.nii.ac.jp/crid/2050025942155225216","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Molecular mechanisms of the medicines for COVID-19"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.coviro.2021.04.006"},{"@type":"CROSSREF","@value":"10.1246/bcsj.20220179_references_DOI_GczKwRGXyWc2hyv9WZlYdNenUkl"},{"@type":"CROSSREF","@value":"10.2142/biophysico.bppb-v18.025_references_DOI_GczKwRGXyWc2hyv9WZlYdNenUkl"},{"@type":"CROSSREF","@value":"10.1021/acs.jcim.2c00946_references_DOI_GczKwRGXyWc2hyv9WZlYdNenUkl"},{"@type":"CROSSREF","@value":"10.1007/s11418-024-01855-6_references_DOI_GczKwRGXyWc2hyv9WZlYdNenUkl"},{"@type":"CROSSREF","@value":"10.3390/ijms22189837_references_DOI_GczKwRGXyWc2hyv9WZlYdNenUkl"},{"@type":"CROSSREF","@value":"10.1248/cpb.c23-00622_references_DOI_GczKwRGXyWc2hyv9WZlYdNenUkl"}]}